Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

96.50 -1.37 (-1.40%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Breaking Down Medtronic: 4 Analysts Share Their Views
 
Via Benzinga
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Via The Motley Fool
Topics Economy World Trade
Medtronic Just Announced a Move That Its Shareholders Should Love
Via The Motley Fool
3 Stocks With 3% to 9% Yields Just Raised Dividends Again
Via MarketBeat
MEDTRONIC PLC (NYSE:MDT) - A Reliable Dividend Stock Worth Considering
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.45% dividend yield with a reliable payout history, strong profitability, and reasonable valuation, making it a compelling choice for dividend investors. 
Via Chartmill
Does This Move Make Medtronic Stock a Buy?
Via The Motley Fool
A Preview Of Medtronic's Earnings
 
Via Benzinga
Mayfair Legal Funding Offers Financial Support to Plaintiffs in Hernia Mesh Litigation
Via Get News
Topics Lawsuit
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Boston Scientific Discontinues Worldwide Sales Of Acurate Aortic Valve Systems: But Retail Sentiment Brightens
The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals... 
Via Stocktwits
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
The company said the regulatory path forward for one of its key systems is too murky to pursue. 
Via Investor's Business Daily
Benzinga Bulls And Bears: Alphabet, L3Harris, Target — And Latest Tariff News Roils Markets
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row
Via The Motley Fool
Topics World Trade
Top S&P500 movers in Thursday's session
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
5 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Thursday's session: gap up and gap down stock in the S&P500 index
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
2 Stocks That Turned $1,000 Into More Than $8,000 in 10 Years to Buy and Hold
Via The Motley Fool
Wall Street Stalls As Yields Rise, Bitcoin Breaks Records Above $109,000: What's Driving Markets Wednesday?
U.S. equities trading was mixed on Wednesday, with major indices showing limited movement by midday as investors remained cautious amid renewed concerns over fiscal policy, which pressured Treasury... 
Via Benzinga
Topics Bonds
Moderna Pulls Application For Seasonal Flu, Covid Combination Vaccine: But Retail Gets More Bullish
Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available. 
Via Stocktwits
XPeng Stock Rises Pre-Market On Upbeat Q1 Earnings, Strong Q2 Forecast: Retail Turns Bullish
For the second quarter, XPeng expects to deliver between 102,000 and 108,000 vehicles, representing a YoY increase of as much as 257.5%. 
Via Stocktwits
Medtronic Dips Despite Quarterly Beat On Plans To Spin Off Diabetes Business
The company beat quarterly expectations and issued strong earnings guidance. But the spinoff plans sent shares lower. 
Via Investor's Business Daily
Topics Government World Trade
Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff
Medtronic plc reported fourth-quarter 2025 sales of $8.93 billion, beating the consensus of $8.82 billion. 
Via Benzinga
Medtronic Announces Split Of Diabetes Business As Standalone Public Company: Retail’s Unmoved
The separation is expected to be accretive to Medtronic’s earnings and operating margin, the company said. 
Via Stocktwits
Topics World Trade
Earnings Scheduled For May 21, 2025
 
Via Benzinga
Nasdaq, S&P 500 Futures Lower After Market Snaps 6-Day Rally: Strategist Warns Tariff-Induced ‘Growth Scare’ Still In Play
On Tuesday, nine of the 11 sector classes closed in the red, with the defensive consumer staple, utility and healthcare stocks bucking the downtrend. 
Via Stocktwits
Topics ETFs Economy Stocks
Ireland: America’s Gateway to Europe – The $2 Trillion Investment Story
Via AB Newswire
Lifeward Appoints Mark Grant As New CEO: Retail Sentiment Dips
Most recently, Grant was President of the Americas and Chief Commercial Officer of IMRA Surgical, a provider of surgical robotic training. 
Via Stocktwits
5 Analysts Assess Medtronic: What You Need To Know
 
Via Benzinga
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Here are three dividend-paying stocks that warrant closer examination. 
Via The Motley Fool
Orchestra BioMed Reports First Quarter 2025 Financial Results and Highlights Recent Regulatory and Clinical Milestones
From Orchestra BioMed Holdings, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
56 57 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.